Top Markets
#1 MowCat MowCat +367.01%
#2 龙虾 (Lobster) 龙虾 (Lobster) +68.62%
#3 SODAX SODAX +47.33%
#4 Cortex Cortex +33.11%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +20.03%
#7 MANTRA MANTRA +18.18%
#8 Akedo Akedo +17.22%
#9 Magma Finance Magma Finance +16.03%
#10 wojak wojak +15.31%
Coin of the day
MowCat MowCat
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Biotest AG Biotest AG

Biotest AG

BIO
Peringkat dalam Saham #7311
Biotest AG is a German biopharmaceutical company focused on the global... Biotest AG is a German biopharmaceutical company focused on the global development, manufacturing, and commercialization of biological medications. The firm organizes its activities into the Therapy, Plasma & Services, and Other segments. Its product portfolio addresses critical needs in hematology, clinical immunology, and intensive care medicine. Among its offerings are treatments for hemophilia A (such as Haemoctin and Vihuma) and hemophilia B (like Haemonine), covering both acute care and prevention. Biotest also provides therapies for various viral infections, including cytomegalovirus (Cytotect CP), hepatitis B (Fovepta, Hepatect, Zutectra), and varicella zoster (Varitect). Additionally, its products, such as Intratect and IgG Next Generation, are utilized for primary and secondary immune deficiencies, autoimmune disorders, and certain neurological conditions. The company further supplies solutions to manage circulating blood volume (Albiomin, Biseko), address clotting factor deficiencies (Cofact, Fibrinogen), and combat serious infections like community-acquired pneumonia and COVID-19 (Trimodulin), as well as general bacterial infections (Pentaglobin). Established in 1946 as Biotest Serum-Institut GmbH, the company adopted its current name, Biotest Aktiengesellschaft, in 1986. Headquartered in Dreieich, Germany, Biotest Aktiengesellschaft has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
Harga Saham
$47.45
Terakhir disinkronkan: 2026-05-13
Kapitalisasi Pasar
$1.63B
Perubahan (1 hari)
2.04%
Perubahan (1 tahun)
3.15%
Negara
DE
Perdagangan Biotest AG (BIO)

Kategori

Healthcare
Laba untuk Biotest AG (BIO)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Biotest AG, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Biotest AG dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH